Last reviewed · How we verify
NCT06782438: IATOS2
Evaluation of an Artificial Intelligence Algorithm Reducing Noise on Fast Whole-body Bone Tomoscintigraphy Acquisitions Recorded by a 360 Degree Cadmium-Zinc-Tellurid Camera
trial testing artificial intelligence algorithm in Bone Scan in 20 participants. Currently enrolling.
15 March 2025
Quick facts
| Lead sponsor | Central Hospital, Nancy, France |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 27 February 2025 |
| Primary completion | 15 March 2025 |
| Estimated completion | 30 March 2025 |
| Sites | 1 location across France |
Drugs / interventions tested
- artificial intelligence algorithm
Conditions studied
- Bone Scan — all drugs for Bone Scan →
Sponsor
Central Hospital, Nancy, France
Who can join
Adults 18 to 99, any sex, with Bone Scan. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Recently, artificial intelligence algorithms reducing noise by deep learning have been developed with application to SPECT and PET images. Many studies have reported the possibility of reducing the recording time in bone scintigraphy by applying artificial intelligence algorithms reducing noise
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A deep-learning noise reduction algorithm outperforms the spatial filters previously required for bone SPECT on a high-speed whole-body 360° CZT-camera.
Bahloul A, Rajadhas F, Doyen M, Lamash Y, et al · · 2025 · PMID 41474536 · DOI 10.1186/s13550-025-01344-1
Verify or expand the search:
- PubMed search for NCT06782438
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of artificial intelligence algorithm
Trials testing the same drug.
- NCT05981950 — Real-world of AI in Diagnosing Retinal Diseases · recruiting
Other Central Hospital, Nancy, France trials
Trials by the same sponsor.
- NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
- NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
- NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
- NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
- NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06782438 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
- Last refreshed: 4 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06782438.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing